NYSE:CAHHealthcare
Should Rapiblyk’s Expanded Distribution Through Cardinal Health Signal a Deeper Shift in CAH’s Specialty Strategy?
In January 2026, AOP Health US, LLC announced that its critical care beta-blocker Rapiblyk (landiolol) became more widely available nationwide through Cardinal Health and other major distributors, giving hospitals broader access via their preferred purchasing channels.
This expanded distribution underscores Cardinal Health’s role as a key conduit for specialty and critical care therapies within U.S. hospital and health system supply chains.
We’ll now examine how this enhanced specialty drug...